Cargando…
Novel Thiazolylketenyl Quinazolinones as Potential Anti-MRSA Agents and Allosteric Modulator for PBP2a
Bacterial infections caused by methicillin-resistant Staphylococcus aureus have seriously threatened public health. There is an urgent need to propose an existing regimen to overcome multidrug resistance of MRSA. A unique class of novel anti-MRSA thiazolylketenyl quinazolinones (TQs) and their analo...
Autores principales: | Dai, Jie, Battini, Narsaiah, Zang, Zhonglin, Luo, Yan, Zhou, Chenghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221040/ https://www.ncbi.nlm.nih.gov/pubmed/37241983 http://dx.doi.org/10.3390/molecules28104240 |
Ejemplares similares
-
Flavonoids as Potential anti-MRSA Agents through Modulation of PBP2a: A Computational and Experimental Study
por: Alhadrami, Hani A., et al.
Publicado: (2020) -
1453. PBP2, PBP2a and PBP4 Clone-specific Polymorphisms are not Associated to Ceftaroline (CPT) Susceptibility in Chilean Clinical Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Spencer, Maria de los Angeles, et al.
Publicado: (2020) -
PBP2a substitutions linked to ceftaroline resistance in MRSA isolates from the UK
por: Harrison, Ewan M., et al.
Publicado: (2016) -
Monoclonal antibody anti-PBP2a protects mice against MRSA (methicillin-resistant Staphylococcus aureus) infections
por: Saraiva, Felipe Betoni, et al.
Publicado: (2019) -
Synthesis and cytotoxic evaluation of novel quinazolinone derivatives as potential anticancer agents
por: Poorirani, Safoora, et al.
Publicado: (2018)